Abstract:Glucocorticoid (GC) has been shown to affect the neuronal survival/death through a genomic mechanism, but whether or not it does through a nongenomic mechanism is unknown. Using a previously identified GR-deficient primary hippocampal neuron culture, we show here that a 15-min coexposure of N-methyl-D-aspartate (NMDA) with corticosterone at a stress-induced level significantly enhances neuronal death compared to NMDA alone. This enhancing effect of GC can be mimicked by the BSA-conjugated corticosterone, which is plasma membrane impermeable and cannot be blocked by RU38486 spironolactone. Furthermore, using a calcium-imaging technique, we found that B could increase both the percentage of neurons showing a significant increment of intracellular free calcium ([Ca2+](i)) due to NMDA stimulation and the amplitude of [Ca2+](i) increment in the individual responsive cells. Interestingly, this boosting effect of GC on [Ca2+](i) increment could be blocked by the NMDA receptor subunit 2A (NR2A)-specific antagonist [(R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) but not by the NMDA receptor subunit 2B (NR2B)-specific antagonist Ro25-6981. Moreover, we also found that GC can dramatically attenuate the NMDA-induced activation of ERK1/2 without affecting that of p38; and that the NMDA-induced ERK1/2 activation and its attenuation by GC both can be occluded by the NVP-AAM077 but not by Ro25-6981. Consistently, the enhancing effect of GC on NMDA neurotoxicity can also be blocked by NVP-AAM077 and the ERK1/2 inhibitor PD98059 but not by Ro25-6981 and p38 inhibitor SB203580. Indeed, the NMDA neurotoxicity itself can be blocked by Ro25-6981 or SB203580, whereas it is increased by NVP-AAM077 and PD98059. Therefore, it is probable that NMDA triggers a prodeath signaling through the NR2B-p38 MAPK pathway, and a prosurvival signaling through the NR2A-ERK1/2 MAPK pathway, whereas the latter was negatively regulated by rapid GC action. Taken together, the present data suggest a nongenomic action by GC that enhances NMDA neurotoxicity through facilitating [Ca2+](i) increment and attenuating the NR2A-ERK1/2-mediated neuroprotective signaling, implicating a novel pathway underlying the regulatory effect of GC on neuronal survival/death.

Blockage of Glucocorticoid Receptors During Memory Acquisition, Retrieval and Reconsolidation Prevents the Expression of Morphine- Induced Conditioned Place Preferences in Mice

Over-expression of the GluN2B Subunit in the Forebrain Facilitates the Acquisition of Morphine-Related Positive and Aversive Memory in Rats

Blocking Alpha(4)Beta(2) And Alpha(7) Nicotinic Acetylcholine Receptors Inhibits The Reinstatement Of Morphine-Induced Cpp By Drug Priming In Mice

Cannabinoid 1 Receptor Blockade in the Dorsal Hippocampus Prevents the Reinstatement but Not Acquisition of Morphine-Induced Conditioned Place Preference in Rats

Blockade of Cannabinoid CB1 Receptor Attenuates the Acquisition of Morphine-Induced Conditioned Place Preference along with a Downregulation of ERK, CREB Phosphorylation, and BDNF Expression in the Nucleus Accumbens and Hippocampus.

Stress Impairs Reconsolidation Of Drug Memory Via Glucocorticoid Receptors In The Basolateral Amygdala

Mglur5 in the Nucleus Accumbens Shell Regulates Morphine‐associated Contextual Memory Through Reactive Oxygen Species Signaling

Phosphorylation of GluN2B Subunits of N-methyl-d-aspartate Receptors in the Frontal Association Cortex Involved in Morphine-Induced Conditioned Place Preference in Mice.

Blockade of mGluR5 in nucleus accumbens modulates calcium sensor proteins, facilitates extinction, and attenuates reinstated morphine place preference in rats

Postretrieval Microinjection of Baclofen into the Agranular Insular Cortex Inhibits Morphine-Induced CPP by Disrupting Reconsolidation

Glucocorticoid Rapidly Enhances NMDA-evoked Neurotoxicity by Attenuating the NR2A-containing NMDA Receptor-Mediated ERK1/2 Activation.

Re-Exposure to Morphine-Associated Context Facilitated Long-Term Potentiation in the Vsub-Nac Glutamatergic Pathway Via Glun2b-Containing Receptor Activation

Essential Role of the NO Signaling Pathway in the Hippocampal CA1 in Morphine-Associated Memory Depends on Glutaminergic Receptors

Role of the No/Sgc/Pkg Signaling Pathway of Hippocampal Ca1 in Morphine-Induced Reward Memory

The NO/sGC/PKG Signaling Pathway in the NAc Shell is Necessary for the Acquisition of Morphine-Induced Place Preference.

Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats

The role of CA3-LS-VTA loop in the formation of conditioned place preference induced by context-associated reward memory for morphine.

Effects of Scopolamine and Ketamine on Reconsolidation of Morphine Conditioned Place Preference in Rats

Inhibition of nuclear factor-κB impairs reconsolidation of morphine reward memory in rats.

Epigenetic Upregulation of Hippocampal CXCL12 Contributes to Context Spatial Memory-Associated Morphine Conditioning.

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.